Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared on X/Twitter:
“Fascinating keynote by Dr. Christine Lovly. Ground breaking advances in thoracic oncology in the past two decades, exemplified by developments of EGFR targeting therapies. So much work has been accomplished by pioneers and giants in the field (many of whom in the audience).”
Source: Chul Kim/X
